{
  "id": 547,
  "text": "Lymphedema was significantly associated with radical hysterectomy with pelvic lymphadenectomy.# 10.1.2 Primary chemoradiotherapy Kong et al.536 compared treatment outcomes and treatment–related morbidities of radical hysterectomy followed by adjuvant therapy (radiotherapy or chemoradiotherapy) and primary chemoradiotherapy in patients with FIGO stages IB-IIA cervical cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Lymphedema was significantly associated with radical hysterectomy with pelvic lymphadenectomy.# 10.1.2 Primary chemoradiotherapy Kong et al.536 compared treatment outcomes and treatment–related morbidities of radical hysterectomy followed by adjuvant therapy (radiotherapy or chemoradiotherapy) and primary chemoradiotherapy in patients with FIGO stages IB-IIA cervical cancer.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于FIGO IB-IIA期的宫颈癌患者，治疗选择通常包括根治性子宫切除术联合辅助治疗（放疗或放化疗）以及初始同步放化疗。根治性子宫切除术后进行辅助治疗与单纯的初始同步放化疗相比，在治疗结果和并发症方面存在一些差异。\n\n根治性子宫切除术联合辅助治疗可能会增加一些手术相关的并发症风险，如淋巴水肿。这是因为手术中包括盆腔淋巴结清扫，而这种清扫容易导致淋巴液回流受阻，进而引发淋巴水肿。此外，手术可能导致其他手术并发症，如感染、出血、膀胱或直肠损伤等。\n\n另一方面，初始同步放化疗的患者可能避免了一些手术相关的并发症，但放化疗本身也可能导致一些特有的放射性损伤，如对膀胱和直肠的放射损伤，以及化疗药物相关的毒性反应。这种方法在治疗效果方面可以直接对癌细胞进行放射损伤，同时通过化疗增强放疗效果。\n\n综上所述，患者选择治疗方案时需要综合考虑治疗效果、并发症风险以及个人健康状况，最好在专业医生的建议下进行决策。",
  "query": "根据提供的<text>内容，问题可以是：\n\n**对于FIGO IB-IIA期的宫颈癌患者，根治性子宫切除术联合辅助治疗与单纯初始同步放化疗相比，在治疗结果和相关并发症方面有哪些差异？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据提供的<text>内容，问题可以是：\n\n**对于FIGO IB-IIA期的宫颈癌患者，根治性子宫切除术联合辅助治疗与单纯初始同步放化疗相比，在治疗结果和相关并发症方面有哪些差异？**\n\n<reference text>: Lymphedema was significantly associated with radical hysterectomy with pelvic lymphadenectomy.# 10.1.2 Primary chemoradiotherapy Kong et al.536 compared treatment outcomes and treatment–related morbidities of radical hysterectomy followed by adjuvant therapy (radiotherapy or chemoradiotherapy) and primary chemoradiotherapy in patients with FIGO stages IB-IIA cervical cancer.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于FIGO IB-IIA期的宫颈癌患者，治疗选择通常包括根治性子宫切除术联合辅助治疗（放疗或放化疗）以及初始同步放化疗。根治性子宫切除术后进行辅助治疗与单纯的初始同步放化疗相比，在治疗结果和并发症方面存在一些差异。\n\n根治性子宫切除术联合辅助治疗可能会增加一些手术相关的并发症风险，如淋巴水肿。这是因为手术中包括盆腔淋巴结清扫，而这种清扫容易导致淋巴液回流受阻，进而引发淋巴水肿。此外，手术可能导致其他手术并发症，如感染、出血、膀胱或直肠损伤等。\n\n另一方面，初始同步放化疗的患者可能避免了一些手术相关的并发症，但放化疗本身也可能导致一些特有的放射性损伤，如对膀胱和直肠的放射损伤，以及化疗药物相关的毒性反应。这种方法在治疗效果方面可以直接对癌细胞进行放射损伤，同时通过化疗增强放疗效果。\n\n综上所述，患者选择治疗方案时需要综合考虑治疗效果、并发症风险以及个人健康状况，最好在专业医生的建议下进行决策。"
}